Difference in safety and humoral response to mRNA SARS-CoV-2 vaccines in patients with autoimmune neurological disorders: the ANCOVAX study.
Giannoccaro MP, Vacchiano V, Leone M, Camilli F, Zenesini C, Panzera I, Balboni A, Tappatà M, Borghi A, Salvi F, Lugaresi A, Rinaldi R, Di Felice G, Lodi V, Lazzarotto T, Liguori R; ANCOVAX study group.
Giannoccaro MP, et al. Among authors: vacchiano v.
J Neurol. 2022 Aug;269(8):4000-4012. doi: 10.1007/s00415-022-11142-7. Epub 2022 May 3.
J Neurol. 2022.
PMID: 35503375
Free PMC article.